Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
Public ClinicalTrials.gov record NCT02335983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1b Study of Carfilzomib Administered Once Weekly in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to assess the safety, tolerability and activity of a once-weekly regimen of carfilzomib in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma.
Study identification
- NCT ID
- NCT02335983
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015 (Actual)
- Primary completion
- Oct 28, 2019 (Actual)
- Completion
- Oct 28, 2019 (Actual)
- Last update posted
- Nov 6, 2020
2015 – 2019
United States locations
- U.S. sites
- 59
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Bakersfield | California | 93309 | — |
| CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center | Bakersfield | California | — | — |
| Research Site | Burbank | California | 91505 | — |
| Providence Saint Joseph Medical Center | Burbank | California | — | — |
| Research Site | Fountain Valley | California | 92708 | — |
| Compassionate Care Research Group, Inc. | Fountain Valley | California | — | — |
| Research Site | Los Angeles | California | 90017 | — |
| Research Site | Los Angeles | California | 90095-1686 | — |
| Los Angeles Hematology / Oncology Medical Group | Los Angeles | California | — | — |
| Research Site | Whittier | California | 90603 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| University of Colorado | Aurora | Colorado | — | — |
| Research Site | Washington D.C. | District of Columbia | 20057 | — |
| Lombardi Cancer Center, Pediatric Hematology Oncology | Washington D.C. | District of Columbia | — | — |
| Research Site | Fort Myers | Florida | 33905 | — |
| Florida Cancer Specialists | Fort Myers | Florida | — | — |
| Research Site | Tampa | Florida | 33612 | — |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | — | — |
| Research Site | West Palm Beach | Florida | 33401 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | — | — |
| University of Chicago Medical Center | Chicago | Illinois | — | — |
| Research Site | Boston | Massachusetts | 02114 | — |
| Dana Farber Partners Cancer Care | Boston | Massachusetts | — | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Hackensack | New Jersey | 07601 | — |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | — | — |
| Research Site | New York | New York | 10021 | — |
| Research Site | New York | New York | 10065 | — |
| Clinical Research Alliance | New York | New York | — | — |
| Memorial Sloan Kettering | New York | New York | — | — |
| Morton Coleman, MD | New York | New York | — | — |
| Weill Cornell Medical College | New York | New York | — | — |
| Research Site | Stony Brook | New York | 11794 | — |
| Stony Brook University Medical Center | Stony Brook | New York | — | — |
| Research Site | Durham | North Carolina | 27705 | — |
| Durham Veterans Affairs Medical Center | Durham | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Sarah Cannon Research Institute | Cincinnati | Ohio | — | — |
| Research Site | Bend | Oregon | 97701 | — |
| Bend Memorial Clinic | Bend | Oregon | — | — |
| Research Site | Charleston | South Carolina | 29424 | — |
| Medical University of South Carolina, Hollings Cancer Center | Charleston | South Carolina | — | — |
| Research Site | Greenville | South Carolina | 29607 | — |
| Greenville Health System | Greenville | South Carolina | — | — |
| Saint Francis Hospital Cancer Center | Greenville | South Carolina | — | — |
| Research Site | Sioux Falls | South Dakota | 57105 | — |
| Avera Cancer Institute | Sioux Falls | South Dakota | — | — |
| Research Site | Germantown | Tennessee | 38138 | — |
| The West Clinic, PC | Memphis | Tennessee | — | — |
| Research Site | Nashville | Tennessee | 37203 | — |
| Research Site | Nashville | Tennessee | 37232 | — |
| Tennessee Oncology, PLLC / The Sarah Cannon Research lnstitute | Nashville | Tennessee | — | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | — | — |
| Research Site | Salt Lake City | Utah | 84112 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | — | — |
| Research Site | Seattle | Washington | 98104 | — |
| Swedish Cancer Institute | Seattle | Washington | — | — |
| Aurora Health Care, Aurora Cancer Care | Milwaukee | Wisconsin | — | — |
| Research Site | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02335983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2020 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02335983 live on ClinicalTrials.gov.